When should one consider tyrosine kinase inhibitor therapy for medullary thyroid cancer? 153
0 צפיות
• 07/10/23
0
0
לְשַׁבֵּץ
administrator
מנויים
Originally presented at the 23rd International Thyroid Cancer Survivors’ Virtual Conference held October 23-25, 2020.
When should one consider tyrosine kinase inhibitor therapy for medullary thyroid cancer? Robert F. Gagel, MD, Endocrinologist, and Mark E. Zafereo, MD, Head and Neck Surgeon.
להראות יותר
תגובות בפייסבוק
SORT BY-
תגובות ראשיות
-
תגובות אחרונות